RK&O featured in "NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical" published by West

Print PDF
July 12, 2019

Richards Kibbe & Orbe LLP represented Greenlight Capital in connection with its recently completed private investment in NeuBase Therapeutics, Inc., a publicly traded company (Nasdaq: NBSE).  NeuBase is a biotechnology company developing next generation antisense therapies to address genetic diseases.

In this press release, RK&O is highlighted for their work as legal counsel for Greenlight Capital. The RK&O team consisted of partner Eric O'Meara.

To read the full release click here.